ARTICLE | Company News
Memorial Sloan Kettering, Gritstone Oncology deal
February 1, 2016 8:00 AM UTC
Memorial Sloan granted Gritstone exclusive, worldwide rights to IP, research data and bioinformatics tools to support discovery and development of tumor-specific, neo-antigen-based immunotherapies to ...